Comparative activities of eight quinolones against members of the Bacteroides fragilis group
Open Access
- 1 June 1994
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (6) , 1442-1445
- https://doi.org/10.1128/aac.38.6.1442
Abstract
The in vitro activities of five new quinolones (clinafloxacin [CI-960 or PD-127391], BAY Y 3118, E-4868, E-5065, and E-5068) against 100 Bacteroides fragilis group bacterial isolates were compared with those of ciprofloxacin, ofloxacin, and sparfloxacin. Overall, E-5068 was the most active in vitro (MIC for 90% of isolates tested [MIC90], 0.25 microgram/ml); this was followed by clinafloxacin and BAY Y 3118 (MIC90, 0.5 microgram/ml). Ciprofloxacin, sparfloxacin, and ofloxacin were the least active (MIC90s, 64, 16, and 16 micrograms/ml, respectively). B. fragilis and Bacteroides caccae were more susceptible than the other members of the B. fragilis group to all of the quinolones tested.Keywords
This publication has 16 references indexed in Scilit:
- Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1991
- In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacinAntimicrobial Agents and Chemotherapy, 1991
- Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesAntimicrobial Agents and Chemotherapy, 1991
- Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituentAntimicrobial Agents and Chemotherapy, 1990
- Evolution of Antimicrobial Susceptibility in Isolates of the Bacteroides fragilis Group in SpainClinical Infectious Diseases, 1990
- The in-vitro activity of PD127,391, a new quinoloneJournal of Antimicrobial Chemotherapy, 1988
- The QuinolonesMayo Clinic Proceedings, 1987
- Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitalsAntimicrobial Agents and Chemotherapy, 1985
- Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid AnalogAntimicrobial Agents and Chemotherapy, 1980